Mycophenolate Mofetil 250 mg/1 (Mycophenolate Mofetil CAPSULE) 250 mg/1

Mycophenolate Mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Camber Pharmaceuticals, Inc. in the USA.

Strength

250 mg/1

Pack Size

1 BOTTLE in 1 CARTON (31722-878-01) / 100 CAPSULE in 1 BOTTLE

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mycophenolate Mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It works by suppressing the immune system to help the body accept the new organ. This medication is often prescribed in combination with other immunosuppressants. People may ask, 'What is Mycophenolate Mofetil used for?' and the answer is typically related to transplant rejection prevention.

Side Effects

Common effects of Mycophenolate Mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some individuals might experience fatigue or changes in blood cell counts. It's important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Mycophenolate Mofetil should be handled with care, as it can affect the immune system. It is essential to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should consult their healthcare provider due to potential risks.

Avoid Interactions

Mycophenolate Mofetil may interact with other medications, including certain antivirals, antibiotics, and immunosuppressants. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

Mycophenolate Mofetil is primarily used to prevent organ rejection in transplant patients.

Mycophenolate Mofetil is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include nausea, vomiting, diarrhea, and abdominal pain.

Pregnant women or those planning to become pregnant should consult their healthcare provider before taking Mycophenolate Mofetil.

If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.